-
Even as medical caregivers try to change practices, racial disparities in hospice care continue, according to a study in the March 8 issue of the Archives of Internal Medicine......
-
Geisinger Health System and Yale School of Medicine investigators are researching how young people recover from heart attacks through VIRGO (Variation in Recovery: Role of Gender on Outcomes in Young AMI Patients), a research project funded by the National, Heart, Lung and Blood Institute......
-
Scivanta Medical Corporation (OTC Bulletin Board: SCVM), announced that the results of its initial clinical trial for the Scivanta Cardiac Monitoring System (SCMS) clearly indicate that the SCMS can accurately measure cardiac performance as expected by the company. This clinical trial was performed at Kaleida Health/Millard Fillmore Hospital in Buffalo, ...
-
BG Medicine, Inc. announced that it has entered into an agreement with Abbott Laboratories (NYSE: ABT) to extend its current development and commercialization collaboration to include the development of a galectin-3 test for Abbott Point of Care's i-STAT® System. Galectin-3 is a novel biomarker that may play a role in ...
-
Evaluating children for underlying heart problems before prescribing stimulant medications can identify children at risk for sudden cardiac death, but electrocardiogram (ECG) screening is of borderline cost-effectiveness compared to current practice, according to research reported in Circulation: Journal of the American Heart Association......
-
A long-acting ACE inhibitor used to reduce blood pressure significantly decreased the risk for cardiovascular disease, including stroke, in normal weight, overweight and obese patients, according to research reported in Hypertension: Journal of the American Heart Association......
-
The DASH diet, combined with exercise and calorie restriction, improved mental functioning by 30 percent in overweight adults with high blood pressure compared to those who didn't diet or exercise, researchers reported in Hypertension: Journal of the American Heart Association......
-
Building on previous studies that found racial differences in hospice use, a new study from the Institute for Aging Research of Hebrew SeniorLife and Boston University School of Medicine finds that blacks and Hispanics use hospice for advanced heart failure at a rate of up to 50 percent less than ...
-
Cardiovascular death is the most common cause of mortality among Type 2 diabetics and claims the lives of millions each year, with many diabetics experiencing their first "symptom" as a heart attack or sudden death. Understanding that diabetics are at high risk for Coronary Heart Disease (CHD) and that many ...
-
A significant number of people with heart disease will benefit from less invasive transcatheter heart valve replacements in future, finds a review of updated practices in CMAJ (Canadian Medical Association Journal)......
-
Medical device pioneer Stentys announced that it has received CE Marking for its self-expanding and disconnectable stent to treat acute coronary syndrome (ACS)......
-
Arthur "Buzz" Brown, founder, president and CEO of ChanTest and renowned authority on cardiotoxicity in drug development, will speak on the subject at the annual meeting of the Society of Toxicology in Salt Lake City, Utah on March 8. Dr. Brown's session, which addresses the problem of sudden cardiac death ...
-
Diabetes affects approximately 8 percent of the people in the United States and adults with diabetes have heart disease death rates two to four times higher than adults without diabetes, according to the American Diabetes Association......
-
To bring the latest in cardiovascular X-ray technology to its pediatric patients, Children's Mercy Hospitals and Clinics in Kansas City, Mo., has installed two InfinixTM CF-i/BP vascular X-ray systems with 8" x 8" flat panel detectors (FPD) from Toshiba America Medical Systems, Inc. These systems are the first pediatric bi-plane ...
-
The Imaging & Knowledge Management business unit of Siemens Healthcare will conduct strategic discussions with customers and prospects on utilizing advanced imaging IT software in their healthcare facilities, during the Healthcare Information and Management Systems Society (HIMSS) Annual Meeting, March 1-4, in Atlanta......
-
On March 4, SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced that its new Freedom™ driver system has received the CE Mark to power the Total Artificial Heart in Europe. "The new Freedom driver is the first wearable portable driver for powering the Total Artificial ...
-
New Saint Louis University research has found that beta blockers, a class of drugs used to prevent the progression of heart failure and manage arrhythmias (irregular heart beat) and hypertension (high blood pressure), are underused in heart failure patients who receive implantable cardiac devices......
-
St. Jude Medical, Inc. (NYSE:STJ) announced publication of clinical results in the Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) trial......
-
The research foundation of the nation's largest group of thoracic surgeons has awarded University of Michigan's Jennifer C. Hirsch, M.D., M.S., with the Nina Starr Braunwald award, a top award for women in cardiac surgery. Hirsch, a cardiac surgeon at the University of Michigan Cardiovascular Center, is an author and ...
-
A Cedars-Sinai Heart Institute cardiologist co-authored the joint science advisory issued by the American Heart Association and the American College of Cardiology that calls for close monitoring of patients taking certain blood sugar-lowering drugs. Sanjay Kaul, M.D. co-authored the advisory about drugs called thiazolidinediones (TZDs) such as pioglitazone (Actos) or ...
